Division for Biochemistry of Joint and Connective Tissue Diseases, Department of Orthopedics, Ulm University Medical Center, 89081, Ulm, Germany.
Institute of Orthopedic Research and Biomechanics, Ulm University Medical Center, 89081, Ulm, Germany.
Cell Mol Biol Lett. 2023 Sep 30;28(1):76. doi: 10.1186/s11658-023-00489-y.
During aging and after traumatic injuries, cartilage and bone cells are exposed to various pathophysiologic mediators, including reactive oxygen species (ROS), damage-associated molecular patterns, and proinflammatory cytokines. This detrimental environment triggers cellular stress and subsequent dysfunction, which not only contributes to the development of associated diseases, that is, osteoporosis and osteoarthritis, but also impairs regenerative processes. To counter ROS-mediated stress and reduce the overall tissue damage, cells possess diverse defense mechanisms. However, cellular antioxidative capacities are limited and thus ROS accumulation can lead to aberrant cell fate decisions, which have adverse effects on cartilage and bone homeostasis. In this narrative review, we address oxidative stress as a major driver of pathophysiologic processes in cartilage and bone, including senescence, misdirected differentiation, cell death, mitochondrial dysfunction, and impaired mitophagy by illustrating the consequences on tissue homeostasis and regeneration. Moreover, we elaborate cellular defense mechanisms, with a particular focus on oxidative stress response and mitophagy, and briefly discuss respective therapeutic strategies to improve cell and tissue protection.
在衰老和创伤后,软骨和骨细胞会暴露于各种病理生理介质中,包括活性氧(ROS)、损伤相关分子模式和促炎细胞因子。这种有害环境会引发细胞应激和随后的功能障碍,不仅导致相关疾病(即骨质疏松症和骨关节炎)的发展,还会损害再生过程。为了对抗 ROS 介导的应激并减少整体组织损伤,细胞具有多种防御机制。然而,细胞抗氧化能力有限,因此 ROS 积累会导致异常的细胞命运决定,这对软骨和骨稳态有不良影响。在这篇综述中,我们将探讨氧化应激作为软骨和骨中病理生理过程的主要驱动因素,包括衰老、定向分化、细胞死亡、线粒体功能障碍和受损的线粒体自噬,通过说明其对组织稳态和再生的影响来阐明这一点。此外,我们详细阐述了细胞防御机制,特别关注氧化应激反应和线粒体自噬,并简要讨论了改善细胞和组织保护的相应治疗策略。
Cell Mol Biol Lett. 2023-9-30
Biochim Biophys Acta. 2016-4
Arch Gerontol Geriatr. 2024-10
Acta Orthop. 2016-12
J Orthop Translat. 2025-8-26
Immunotargets Ther. 2025-8-21
Front Endocrinol (Lausanne). 2025-7-21
Front Endocrinol (Lausanne). 2025-7-9
Osteoporos Int. 2025-7-15
MedComm (2020). 2025-7-1
Cell Mol Biol Lett. 2023-6-27
Osteoarthritis Cartilage. 2023-9
Autophagy. 2023-9
Antioxidants (Basel). 2023-2-3
Front Endocrinol (Lausanne). 2023
Arthritis Res Ther. 2022-12-31
Cell Death Discov. 2022-12-15